Author: therawinformant

Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Jessica Smith discuss President Trump’s executive actions extending aids to Americans affected by COVID-19, and China’s sanctions on 11 U.S. citizens.

from Yahoo Finance https://ift.tt/3iqF1mx

AstraZeneca has entered into an agreement with Shenzhen Kangtai Biological Products to manufacture and supply its coronavirus vaccine candidate, AZD1222, in mainland China.Under the terms of the exclusive cooperation agreement, Shengzhen Kangtai Bio commits to ensure annual production capacity of at least 100 million doses of AstraZeneca (AZN) potential vaccine AZD1222 by the end of this year. To meet the needs of the Chinese market, the Chinese vaccine maker needs to boost capacity to at least 200 million doses by the end of 2021, according to the agreement.The two partners said that they will explore the possibility of cooperation in other regions and markets.AstraZeneca, which is developing AZD1222 together with Oxford University, has in recent weeks signed supply chain agreements for the capacity to produce 2 billion doses of its vaccine candidate. The British drugmaker has inked supply deals with the U.S. and European Union countries.  Late-stage Phase II/III trials are currently underway in the UK, Brazil and South Africa and are due to start in the US, AstraZeneca said.AZD1222 is one of several vaccine candidates supported by Operation Warp Speed (OWS), the U.S. government program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines available for Americans by Jan. 2021.AstraZeneca shares have advanced 11% this year as the drugmaker joined the list of companies engaged in the development of a potential coronavirus vaccine. Looking ahead, the $81.84 average analyst price target puts the upside potential at a promising 48% in the coming 12 months.Overall, the stock scores a Strong Buy consensus from the analyst community based on 3 unanimous Buy ratings. (See AstraZeneca stock analysis on TipRanks)Related News: Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease Moderna Secures $400M In Deposits For Supply Of Covid-19 Vaccine Candidate Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab More recent articles from Smarter Analyst: * JMP Securities Lifts Zillow PT On Strong 2Q * Wedbush Lifts Apple's PT To ‘Street High’ * PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined * Pfizer Inks Deal To Manufacture Gilead’s Covid-19 Remdesivir Treatment

from Yahoo Finance https://ift.tt/3ao7K93

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also…

from Yahoo Finance https://ift.tt/30GMuYM

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]

from Yahoo Finance https://ift.tt/33Jm3DJ

Tesla Inc (NASDAQ: TSLA) paid nearly $100 million for the 2,000-acre land on which it plans to build its latest gigafactory, Electrek reported Sunday.What Happened The former owner of the property, TXI Operations LP, a unit of Martin Marietta Inc (NYSE: MLM), revealed in an earnings call on July 28 that it sold a "depleted standing gravel location" for $97 million, as earlier reported by local Austin media.TXI IOperations didn't give further details on the property it sold, or the name of the buyer, but according to Electrek, the reference is to none other than Tesla's under-construction manufacturing facility near Austin, Texas.The electric vehicles maker had purchased the land through its subsidiary Colorado River Project, LLC. Why It Matters Heavy machinery has been spotted at the site since the last month, on all days of the week, Electrek noted. The scale of the upcoming factory is impressive and the new facility could potentially become one of the world's largest buildings, upon completion.CEO Elon Musk said on the company's second-quarter earnings call that the Texas factory would have walking paths and other natural features for the public to enjoy.The Gigafactory would primarily be used to build the company's all-electric pickup vehicle, the Cybertruck.Price Action Tesla shares closed 2.48% lower at $1,452.71 on Friday.See more from Benzinga * Chinese Tesla, Nio Rival Xpeng Files To Go Public On NYSE * Hyundai Shares Soar 15% In Seoul As It Announces Dedicated Electric Vehicle Brand * Tesla Battery Supplier LG Chem Expects Revenue To More Than Double At .3B In 5 Years(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

from Yahoo Finance https://ift.tt/2CddhSY

Cisco (CSCO) has announced that it has completed the acquisition of ThousandEyes. The deal for the internet and cloud intelligence platform, worth a reported $1 billion, was first announced in May.According to Cisco, ThousandEyes enables organizations to visualize any network as if it was their own, quickly surface actionable insights, and collaborate and solve problems with service providers.“Cisco’s strength in network and application performance, combined with… ThousandEyes, now allows customers to have an end-to-end view into the digital delivery of applications and services over the internet” the company commented.It will incorporate ThousandEyes capabilities across Cisco’s core Enterprise Networking and Cloud, and AppDynamics portfolios.Shares in Cisco are down 1% on a year-to-date basis, and the stock scores a cautiously optimistic Moderate Buy Street consensus. That’s with an average analyst price target of $50 (5% upside potential).However Robert W Baird analyst Jonathan Ruykhaver is staying sidelined for now. He reiterated a hold rating on Cisco with a $48 price target on August 10 after completing a survey of Cisco partners for F4Q20.“Both F4Q20 feedback and F1Q21 expectations were unsurprisingly muted relative to historic averages” he noted, adding that “Partners have seen and expect to continue to see worsening effects from the coronavirus, and expectations for CY20 growth appear to have deteriorated vs. our prior survey.”Plus the analyst pointed out that partner commentary around competitive pressures in security and collaboration, along with continued expectations for pressures on switching, are also sources of concern.“Overall, we remain Neutral on Cisco given our expectations for both near and longer-term headwinds to growth” Ruykhaver concluded. (See Cisco stock analysis on TipRanks)Related News: Roper Looking To Snap Up Vertafore For $5.5 Billion- Report Qualcomm Pops 12% In After-Hours On $1.8B Huawei License Deal Logitech Ramps Up Annual Profit Outlook As Q1 Income Leaps 75% More recent articles from Smarter Analyst: * JMP Securities Lifts Zillow PT On Strong 2Q * Wedbush Lifts Apple's PT To ‘Street High’ * PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined * Pfizer Inks Deal To Manufacture Gilead’s Covid-19 Remdesivir Treatment

from Yahoo Finance https://ift.tt/2XM1fI2

It might be of some concern to shareholders to see the Axon Enterprise, Inc. (NASDAQ:AAXN) share price down 13% in the…

from Yahoo Finance https://ift.tt/3gL6Y86

On this episode of Yahoo Finance Presents, Levi Strauss & Co. President and CEO Chip Bergh sat down with Yahoo Finance’s Brian Sozzi to discuss the company’s activity during the coronavirus pandemic, including dispelling the myth of “athleisure” wear affecting sales, the looming uncertainty of the “back to school” clothes shopping season, consumer behavior during COVID-19, as well as future plans for both products and retail and brand expansion.

from Yahoo Finance https://ift.tt/2PECZCX

Potential Tenneco Inc. (NYSE:TEN) shareholders may wish to note that the Independent Director, Thomas Freyman…

from Yahoo Finance https://ift.tt/33L9I1G

(Bloomberg) — Barrick Gold Corp. is returning some of the windfall it’s getting from gold’s record rally to its shareholders.The world’s second-largest gold miner increased its quarterly cash dividend 14% to 8 cents per share, the company said in its second-quarter earnings statement Monday. That’s up from the previous dividend of 7 cents per share.“The board believes that the dividend increase is sustainable and reflects the ongoing robust performance of our operations and continued improvement in the strength of our balance sheet,” the company said.Chief Executive Officer Mark Bristow said the strong cash generation demonstrated the quality of Barrick’s assets and management’s ability to capture the full benefit of higher gold prices.Key InsightsAll-in sustaining costs increased 8.1% to $1,031 an ounce in the second quarter from the previous three months amid precautions for the coronavirus.Barrick said last month those costs likely increased 7% to 9% in the second quarter, compared with the previous three months.Spurred by pandemic-induced economic concerns, gold prices have skyrocketed this year, providing a tailwind for producers of the metal.A Bloomberg Intelligence index of senior gold miners has gained over 50% in 2020.Spot gold prices were up more than 30% on average in the second quarter compared with a year earlier, and last month they shot past the all-time record set in September 2011.Barrick is on track to meet its guidance for 2020 production estimated at a range of 4.6 million to 5 million ouncesThat target was lowered in May in part because of a conflict with the government of Papua New Guinea over its Porgera mine.Market ReactionBarrick rose 1.7% at 6:20 a.m. in New York before the start of regular trading. The shares climbed 55% this year through Friday’s close.Get MoreAdjusted earnings came in at 23 cents a share versus the average analyst estimate of 18 centsFor additional details on the news, click here.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/3irDhcR